Telogen effluvium

L12_TELOGEFFLU

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L65.0# Cause of death: ICD-10 — L65.0# 2 out of 7 registries used, show all original rules.	70
4. Check minimum number of events None	70
5. Include endpoints None	70
6. Filter based on genotype QC (FinnGen only)	69

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L65
Name in latin: Effluvium telogenicum

NAME	L12_TELOGEFFLU
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L650
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L650
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Telogen effluvium based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	541	499	35
Only index persons	520	488	32
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.02	0.02	0.00
Median age at first event (years)
Whole population	37.78	39.08	18.84
Only index persons	38.14	39.45	18.28

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	69	64	5
Unadjusted period prevalence (%)	0.02	0.02	0.00
Median age at first event (years)	49.55	49.83	45.88

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
70: Matched controls
700

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L65.0

ICD-10 Finland

Telogen effluvium

+∞

100.6

D07AC01

ATC

betamethasone; topical

4.8

9.6

167

C03DA01

ATC

spironolactone; oral

6.1

9.2

L65.9

ICD-10 Finland

Nonscarring hair loss, unspecified

89.1

7.6

L73.8

ICD-10 Finland

Other specified follicular disorders

+∞

7.4

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3020717) Zinc [Moles/volume] in Serum or Plasma

12.67

5.46

1.1

1.0

18.42

21.86

umol/l

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

588

+∞

4.72

21.6

12.7

22.43

18.10

mg/l

0.43

443

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

8.85

4.18

1.0

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

10.93

4.10

1.3

1.4

—

(3037522) Nuclear Ab [Titer] in Serum

2.76

3.39

1.5

192.00

513.60

titre

—

(3019225) pH of Specimen

3.24

3.11

6.2

5.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

280

2.39

3.07

8.8

5.1

—

(40768797) Stomach Pathology biopsy report

2.70

3.04

1.1

1.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

10.62

3.02

1.4

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

5.85

2.95

1.0

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.93

2.82

1.4

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

288

2.28

2.78

5.0

2.5

107.49

78.15

ug/l

0.53

266

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

226

2.22

2.70

2.4

1.8

99.12

101.57

pmol/l

0.11

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

7.58

2.59

1.2

1.0

—

(3001604) Monocytes [#/volume] in Blood

289

2.13

2.41

9.1

5.2

0.55

0.54

e9/l

0.17

262

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

133

2.22

2.39

1.3

13.23

25.14

iu/ml

—

(3006315) Basophils [#/volume] in Blood

290

2.12

2.38

9.1

5.2

0.05

0.04

e9/l

1.08

261

(3037467) Urinalysis macro (dipstick) panel - Urine

414

2.33

2.31

6.7

4.2

—

(3019198) Lymphocytes [#/volume] in Blood

303

2.09

2.27

9.1

5.1

1.98

1.88

e9/l

0.39

282

(3013115) Eosinophils [#/volume] in Blood

303

2.09

2.27

9.7

5.8

0.20

0.16

e9/l

1.11

278

(40768804) Tissue Pathology biopsy report

247

2.06

2.26

3.1

1.9

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.62

2.26

1.8

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

128

2.19

2.25

6.5

1.7

1.30

0.74

mg/l

0.54

(40768443) Skin Pathology biopsy report

3.97

2.21

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

3.97

2.21

1.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.77

2.11

3.4

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.36

2.11

3.2

1.8

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

5.29

2.10

5.0

2.5

2.70

3.63

g/l

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

157

2.04

1.4

1.2

0.94

1.37

u/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3.58

2.02

1.0

1.4

—

(3042936) Bacteria identified in Isolate by Culture

2.31

1.92

2.2

2.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

269

1.90

1.85

2.8

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2.39

1.85

1.5

3.3

14.00

5.40

umol/l

0.49

(3002256) Pathology report gross observation

2.24

1.81

1.4

1.1

—

(3021589) Normoblasts [#/volume] in Blood

255

1.85

1.71

13.9

7.6

0.00

e9/l

-0.00

210

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.76

1.56

2.3

2.0

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

349

1.81

1.53

10.7

9.1

4.06

4.09

e9/l

0.04

311

(3044889) 12 lead EKG panel

401

1.86

1.52

4.4

3.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

3.28

1.46

1.4

1.1

—

(3022313) Gas panel - Capillary blood

3.28

1.46

4.6

3.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2.57

1.43

1.7

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2.31

1.40

1.9

1.5

—

(3010813) Leukocytes [#/volume] in Blood

662

+∞

1.39

30.2

18.2

6.90

6.45

e9/l

1.16

646

(3035941) MCH [Entitic mass]

662

+∞

1.39

30.0

18.1

30.48

30.11

1.06

652

(3026361) Erythrocytes [#/volume] in Blood

662

+∞

1.39

30.1

18.2

4.35

4.44

e12/l

1.11

647

(3000963) Hemoglobin [Mass/volume] in Blood

662

+∞

1.39

30.1

18.3

132.23

133.27

g/l

0.31

653

(3024731) MCV [Entitic volume]

661

+∞

1.39

30.0

18.2

91.65

90.66

1.01

651

(3007461) Platelets [#/volume] in Blood

661

+∞

1.39

30.3

18.3

273.69

261.60

e9/l

0.79

648

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

133

1.83

1.38

1.2

1.3

30.91

4.34

u/ml

0.41

(3003694) ABO and Rh group [Type] in Blood

168

1.76

1.35

1.5

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.26

1.35

3.0

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.26

1.35

3.0

1.9

—

(3035350) Ketones [Presence] in Urine by Test strip

288

1.70

1.34

3.3

3.5

0.00

estimate

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.64

1.33

3.3

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.64

1.33

3.3

1.8

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.64

1.33

1.7

1.5

—

(3034770) Mitochondria Ab [Titer] in Serum

2.91

1.31

1.4

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.91

1.31

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2.91

1.31

1.8

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

2.91

1.31

3.2

1.4

—

(40761535) Cells panel - Urine sediment

2.38

1.29

8.3

2.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

153

1.75

1.28

1.3

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

136

1.78

1.28

1.6

1.3

2.92

2.14

g/l

0.88

(3022217) INR in Platelet poor plasma by Coagulation assay

225

1.68

1.26

14.1

10.8

1.36

1.16

inr

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.94

1.24

3.4

3.1

5.63

3.93

e6/l

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2.75

1.23

1.2

1.9

0.25

0.23

g/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2.75

1.23

1.2

1.1

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

190

1.69

1.23

4.5

2.7

—

(3045414) Leukocytes [Presence] in Urine

2.43

1.21

2.8

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.87

1.19

9.1

3.7

0.81

0.82

mmol/l

0.14

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

122

1.77

1.18

2.6

2.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

106

1.80

1.16

1.9

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.93

1.16

1.8

1.6

—

(3023368) Bacteria identified in Blood by Culture

123

1.75

1.15

5.8

4.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

123

1.75

1.15

3.9

3.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

449

1.74

1.15

3.9

3.5

—

(36660697) Celiac disease serology panel - Serum

2.03

1.15

1.2

1.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2.32

1.12

2.4

7.4

2.00

1.19

mmol/l

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2.10

1.09

5.3

3.9

4.41

4.64

pmol/l

—

(3000492) Spirometry study

2.03

1.07

1.5

—

(3026008) Bacteria identified in Urine by Culture

187

1.62

1.07

8.3

3.1

—

(3044640) Blood type and Crossmatch panel - Blood

170

1.63

1.04

2.6

2.1

—

(3022145) Colonoscopy Study observation

1.92

1.01

1.5

1.2

—

(3000330) Specific gravity of Urine by Test strip

2.17

0.92

3.0

3.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1.88

0.88

1.1

2.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

290

1.50

0.86

4.7

5.0

0.00

estimate

—

(3000991) Gas panel - Venous blood

1.95

0.84

4.2

8.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

197

1.51

0.83

2.8

3.4

13.68

19.76

ng/l

1.18

123

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.70

0.82

3.5

2.9

0.43

1.15

e6/l

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1.75

0.82

15.0

3.5

224.25

237.77

u/l

—

(3018095) Leukocytes [#/volume] in Urine

207

1.50

0.81

5.3

3.6

13.69

67.05

e6/l

1.65

144

(40758558) Short blood count panel - Blood

162

1.52

0.79

10.0

7.4

—

(3009261) Glucose [Presence] in Urine by Test strip

295

1.45

0.77

3.4

3.5

0.00

estimate

—

(1002224) Polysomnography panel

2.16

0.76

1.2

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.88

0.75

1.3

1.5

—

(4200892) Spirometry reversibility

1.83

0.74

1.1

1.3

—

(3002032) Base excess in Venous blood by calculation

1.70

0.69

3.3

2.3

0.90

2.24

mmol/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.71

0.65

3.9

3.2

—

(4035726) Immunohistochemistry procedure

1.61

0.62

1.9

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.58

0.62

1.9

1.6

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.61

0.0

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.61

0.0

1.8

—

(36304419) Bacteria [Presence] in Urine

152

1.44

0.61

4.0

2.7

—

(3002582) Erythrocytes [#/volume] in Urine

173

1.40

0.56

4.6

2.8

53.30

17.29

e6/l

0.57

129

(3013512) EKG study

155

1.41

0.55

3.6

3.3

—

(3023520) Reticulocytes [#/volume] in Blood

1.59

0.54

2.8

79.90

70.93

e9/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

147

1.40

0.52

2.3

1.5

—

(3000494) Fungus identified in Specimen by Culture

1.55

0.50

2.0

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

561

1.49

0.48

18.9

11.1

81.50

85.80

ml/min/173m2

0.71

445

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.55

0.42

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.00

0.42

0.0

2.4

—

3.90

—

(3020891) Body temperature

0.00

0.41

0.0

3.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

0.00

0.40

0.0

2.4

—

1.51

—

(3025941) Bacteria identified in Stool by Culture

1.42

0.39

2.4

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.61

0.38

1.8

1.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1.51

0.37

1.7

1.6

—

(3022621) pH of Urine by Test strip

1.47

0.36

3.0

2.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.29

0.27

4.6

5.7

—

(3002385) Erythrocyte distribution width [Ratio]

512

1.24

0.25

25.9

15.4

14.70

14.85

0.08

503

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.30

0.23

1.0

—

(3012516) Albumin [Mass/volume] in Urine

127

1.23

0.22

3.7

2.9

49.06

49.71

mg/l

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.00

0.21

0.0

1.3

—

26.48

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.21

0.0

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

176

1.19

0.20

2.0

3.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.20

0.0

3.7

—

89.69

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.17

0.19

4.8

2.1

—

(1761868) Lipid panel - Serum or Plasma

231

0.87

0.15

3.3

2.6

—

(40761536) Microorganisms panel - Urine sediment

1.04

0.09

2.4

3.4

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.16

0.08

3.1

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.09

0.08

1.7

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.15

0.08

2.9

2.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

139

1.10

0.06

3.9

3.3

15.51

8.62

mg/mmol

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

231

1.06

0.03

2.6

3.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

138

1.02

0.00

2.6

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

151

0.99

0.00

2.9

3.6

0.00

estimate

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

8.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

0.28

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

0.89

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

-0.00

0.0

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

25.84

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

-0.00

0.0

1.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

-0.00

0.0

1.2

—

13.00

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

-0.00

0.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

-0.00

0.0

1.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

0.00

-0.00

0.0

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.90

-0.00

2.3

1.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

-0.00

0.0

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

-0.00

0.0

1.6

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

12.23

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

0.90

-0.00

4.2

6.4

102.00

103.96

mmol/l

—

(3036180) Methadone [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3019977) pH of Arterial blood

0.00

-0.00

0.0

2.1

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.3

—

3.89

—

(3021901) Oxygen saturation in Capillary blood

0.00

-0.00

0.0

1.3

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

0.00

-0.00

0.0

1.2

—

119.40

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

2.3

—

107.88

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

-0.00

0.0

1.0

—

31.00

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

97.48

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

60.86

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

241.11

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.4

—

(3045424) Erythrocytes [Presence] in Urine

0.00

-0.00

0.0

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_TELOGEFFLU and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_TELOGEFFLU.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_TELOGEFFLU – Telogen effluvium

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Telogen effluvium

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints